Tuberculosis

Giovanni Battista Migliori is a specialist in respiratory medicine and medical statistics, and an auditor of quality systems. He has over 20 years of experience in design, implementation, and monitoring and evaluation of TB and TB/HIV control programmes globally. Giovanni Battista Migliori is Head of Clinical Epidemiology of the Respiratory Disease Service and Director of the WHO Collaborating Centre for TB and Lung Disease at Maugeri Care and Research Institute (Tradate, Italy). Graham Bothamley has been a respiratory physician for 35 years and has looked after over 4000 patients with TB. He is currently a member of the TB Centre and Immunology and Infections Department at the London School of Hygiene and Tropical Medicine (London, UK) and at the Blizard Institute (Queen Mary University of London, London, UK). Raquel Duarte is the Coordinator of the National Reference Centre for MDR-TB, the Director of the National Programme for TB and Associate Professor at the Medical School and at the Institute of Public Health of Porto University (Porto, Portugal). Adrian Rendon is a specialist in internal medicine and pulmonary and critical care medicine. He is Professor of Medicine at the School of Medicine and the University Hospital of Monterrey of the Universidad Autonoma de Nuevo Leon (Mexico), where he has run a busy TB clinic since 1994.

The patients' perspective; History of tuberculosis; Epidemiology and socioeconomic determinants; Evolution of the strategies for control and elimination; Aetiopathogenesis, immunology and microbiology; Clinical diagnosis; Laboratory diagnosis; Imaging for diagnosis and management; Bronchoscopy and other invasive procedures for diagnosis; Treatment of drug-susceptible and drug-resistant tuberculosis; New and repurposed drugs; Adverse anti-tuberculosis drug events and their management; Surgery as a treatment; Challenges in childhood tuberculosis; Pregnancy and the elderly; Comorbidities; Access and adherence to prevention and care for hard-to-reach groups; Monitoring during and after treatment; Sequelae assessment and rehabilitation; Towards a new vaccine; Transmission control: a refocused approach; Diagnosis and treatment of latent tuberculosis infection; Nontuberculous mycobacteria; What next? Basic research, new treatments and a patient-centred approach; Opportunities for training and learning; Clinical cases.